GeneSoft Pharmaceuticals Overview

  • Founded
  • 1997
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $169M
Latest Deal Amount

GeneSoft Pharmaceuticals General Information

Description

Provider of anti-infective pharmaceuticals. The company specializing in the discovery and development of a quinolone anti-infective product.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Acquirer
Oscient Pharmaceuticals
Primary Office
  • 7300 Shoreline Court
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GeneSoft Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 06-Feb-2004 $169M 000.00 00000 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series D) 14-May-2003 000.00 000.00 00000 Completed Generating Revenue
3. Grant 18-Apr-2003 00.00 000 Completed Generating Revenue
2. Early Stage VC (Series 1) 12-Nov-2002 $3M $3M Completed Startup
1. Grant 01-Jan-2002 $15.3M Completed Startup
To view GeneSoft Pharmaceuticals’s complete valuation and funding history, request access »

GeneSoft Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 0,000,000 00.000000 00 00 00 00 00 00.000
Series C 0,000,000 00.000000 00 00 00 00 00.0 00.000
Series B 6,000,000 $0.000100 8% $2.5 $2.5 1x $2.5 16.86%
Series A 5,425,000 $0.000100 8% $1 $1 1x $1 15.25%
To view GeneSoft Pharmaceuticals’s complete cap table history, request access »

GeneSoft Pharmaceuticals Executive Team (2)

Name Title Board Seat Contact Info
Robert Gundersom Jr. Secretary
You’re viewing 1 of 2 executive team members. Get the full list »

GeneSoft Pharmaceuticals Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BB Bioventures Venture Capital Minority 000 0000 000000 0
LG Life Sciences Corporation Minority 000 0000 000000 0
Ultreia Capital Venture Capital Minority 000 0000 000000 0
To view GeneSoft Pharmaceuticals’s complete investors history, request access »